References
- Chaisson RE, Hopewell PC. Mycobacteria and AIDS mortality. Am Rev Respir Dis 1989; 139 (1): 1–3.
- Young LS, Inderlied CB, Berlin OG, Gottlieb MS. Mycobacterial infections in AIDS patients, with an emphasis on the Mycobacterium avium complex. Rev Infect Dis 1986; 8(6): 1024–1033.
- Horsburg CR. Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Engl J Med 1991; 324 (19): 1332–1338.
- Wenger JD, Whalen CC, Lederman MM et al. Factors in acquired immunodeficiency syndrome. J Gen Inter Med 1988; 3 (5): 464–470.
- Kerlikowske KM, Katz MH, Chan AK, Perez-Stable EJ. Antimycobacterial therapy for disseminated Mycobacterium avium complex infection in patients with acquired immunodeficiency syndrome. Arch Inter Med 1992; 152 (4): 813–817.
- Nightingale SD, Cameron DW, Gordin FM, Sutlam PM, Cohn DL, Chaisson RE. Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS. N Engl J Med 1993; 329 (12): 828–833.
- Siegal FB, Chaisson R, Stern J et al. Clinical manifestations of M. avium complex (MAC) bacteraemia in patients with AIDS. VIII International Conference on AIDS/III STD World Congress. Amsterdam, the Netherlands, July 19–24, 1992. Abstract PoB 3256 book, B129.
- Hoy J, Mijch A, Sandland M, Grayson L, Lucas R, Dwyer B. Quadruple-drug therapy for Mycobacterium avium-intracellulare bacteraemia in AIDS patients. J Infect Dis 1990; 161 (4): 801–805.
- Dautzenberg B, Truffot CH, Mignon A et al. Rifabutin in combination with clofazimine, isoniazid and ethambutol in the treatment of AIDS patients with infections due to opportunistic mycobacteria. Tubercle 1991; 72: 168–175.,
- Oken MM, Creech RH, Torney DC et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol (CCT) 1982; 5: 649–655.
- Young LS, Inderlied CB. Mycobacterium avium complex infections. A comprehensive overview of diagnosis and treatment. AIDS Patient Care [Special rpt] 1990; 4 (5) 10–18.
- Wong B, Edwards FF, Kiehn TE et al. Continuous high-grade Mycobacterium avium intracellulare bacteraemia in patients with the acquired immune deficiency syndrome. Am J Med 1985; 78: 35–40.
- Baron EJ, Young LS. Amikacin, ethambutol and rifampicin for treatment of disseminated Mycobacterium avium-intracellulare infections in patients with acquired immune deficiency syndrome. Diagn Microbiol Infect Dis 1986; 5 (3) 215–220, 1986.
- De Lalla F, Maserati R, Scarpellini P et al. Clarithromycin-ciprofloxacin-amikacin for therapy of Mycobacterium avium-mycobacterium intracellulare bacteraemia in patients with AIDS. Antimicrob Agents Chemother 1992; 36: 1567–1569.
- Dautzenberg B, Truffot C, Legris S et al. Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immunodeficiency syndrome. A con-trolled clinical trial. Am Rev Resp Dis 1991; 144: 564–569.
- Young LS, Wiviott L, Wu L, Kolonoski P, Bolan R, Inderlied CB. Azithromycin for treatment of Mycobacterium avium-intracellulare complex infection in patients with AIDS. Lancet 1991; 338(8775): 1107–1109.
- Hawkins CC, Gold JWM, Whimbey E, et al. Mycobacterium avium complex infections in patients with acquired immunodeficiency syndrome. Ann Intern Med 1986; 105: 184–188.
- Dwyer B, Slivers A, Jackson K, Hoy J, Mijch A. Survival from MAC infections in AIDS. The influence of Rifabutin. Frontiers in mycobacteriology: M. avium, the Modern Epidemic. Vail, Colorado, October 15–19, 1992. Abstract N 54, Abstract Book 32.